Skip to content

PACS医疗集团

US · PACS #1809 按市值排名 上市于 2024
46.91 -0.84 -1.76%
实时 - 追踪5344个代码 - 心跳于507秒前 · 2026-10-16 20:02

最新新闻

  • 评级变动
    J.P. Morgan Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $58
    \u5e02\u573a\u8d44\u8baf · 2026/9/4
  • Form 144 | PACS Group(PACS.US) Officer Proposes to Sell 6.43 Million in Common Stocks
    \u5e02\u573a\u8d44\u8baf · 2026/9/16
  • 评级变动
    Truist Financial Initiates PACS Group(PACS.US) With Buy Rating, Announces Target Price $52
    \u5e02\u573a\u8d44\u8baf · 2026/6/15
  • 评级变动
    UBS Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $60
    \u5e02\u573a\u8d44\u8baf · 2026/8/7
  • 评级变动
    Oppenheimer Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $57
    \u5e02\u573a\u8d44\u8baf · 2026/8/10
  • 评级变动
    Truist Financial Maintains PACS Group(PACS.US) With Buy Rating
    \u5e02\u573a\u8d44\u8baf · 2026/9/2
  • 评级变动
    J.P. Morgan Maintains PACS Group(PACS.US) With Buy Rating, Maintains Target Price $58
    \u5e02\u573a\u8d44\u8baf · 2026/9/8
  • 公司公告
    4: PACS Group | 4: Statement of changes in beneficial ownership of securities-Director LEAVITT TAYLOR S.
    SEC · 2026/7/7
  • 公司公告
    PACS Group | 8-K: PACS Group, Inc. Reports First Quarter 2026 Results
    SEC · 2026/5/12
  • Form 144 | PACS Group(PACS.US) Officer Proposes to Sell 6.61 Million in Common Stocks
    \u5e02\u573a\u8d44\u8baf · 2026/9/16
  • PACS Group(PACS.US) 10% Shareholder Sells US$3.5 Million in Common Stock
    \u5e02\u573a\u8d44\u8baf · 2026/10/6
  • 公司公告
    4: PACS Group | 4: Statement of changes in beneficial ownership of securities-Director LEAVITT TAYLOR S.
    SEC · 2026/6/13
  • 评级变动
    UBS Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $57
    \u5e02\u573a\u8d44\u8baf · 2026/7/8
  • Form 144 | PACS Group(PACS.US) Officer Proposes to Sell 11.21 Million in Common Stocks
    \u5e02\u573a\u8d44\u8baf · 2026/9/11
  • 评级变动
    Truist Financial Maintains PACS Group(PACS.US) With Buy Rating, Announces Target Price $62
    \u5e02\u573a\u8d44\u8baf · 2026/8/7
  • 评级变动
    J.P. Morgan Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $47
    \u5e02\u573a\u8d44\u8baf · 2026/6/23
  • 公司公告
    8-K: PACS Group | 8-K: PACS Group, Inc. Reports Second Quarter 2026 Results
    SEC · 2026/8/5
  • 评级变动
    RBC Capital Maintains PACS Group(PACS.US) With Buy Rating, Raises Target Price to $57
    \u5e02\u573a\u8d44\u8baf · 2026/8/6
  • 公司公告
    PACS Group | 8-K: PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 Results
    SEC · 2026/2/27
  • PACS Group(PACS.US) 10% Shareholder Sells US$13.04 Million in Common Stock
    \u5e02\u573a\u8d44\u8baf · 2026/9/16

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 20:02:15 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

PACS医疗集团 讨论区 0 条评论

发表评论